The integration of automated dissolution testing with online UV/Vis spectroscopy represents the present and future of pharmaceutical quality control. As regulatory expectations continue to evolve toward enhanced data integrity and process understanding, automated systems like the SOTAX Xtend™ provide pharmaceutical laboratories with the capabilities needed to meet these demands while simultaneously improving operational efficiency and reducing costs.
The combination of the Xtend™ system's precision automation with the METTLER TOLEDO UV7 spectrophotometer's fast analytical capabilities delivers a dissolution testing platform that sets new standards for accuracy, reproducibility, and productivity. Laboratories implementing this technology gain immediate operational benefits while positioning themselves for long-term success in an increasingly competitive and regulated pharmaceutical landscape.
The question facing pharmaceutical quality control laboratories is no longer whether to automate dissolution testing, but rather how quickly they can implement automated systems to gain competitive advantages in productivity, data quality, and regulatory compliance. The SOTAX Xtend™ with UV7 detection provides a proven, reliable pathway to dissolution testing excellence, backed by comprehensive validation support, global service infrastructure, and decades of industry expertise.
Investment in automated dissolution testing represents investment in laboratory capability, staff productivity, data quality, regulatory confidence, and competitive position. For pharmaceutical organizations committed to quality excellence and operational efficiency, the Xtend™ automated dissolution system delivers measurable value that extends far beyond the quality control laboratory to impact the entire drug development and manufacturing enterprise.